Key result
Red dragon fruit peel extract reduces NT-proBNP and myocardial injury in diabetic rats.
Why the study?
Diabetes mellitus causes myocardial biochemical and structural alterations involving oxidative stress and inflammation, motivating an evaluation of red dragon fruit peel extract on cardiac biochemical markers and myocardial histopathology in a diabetic rat model.
Does red dragon fruit peel extract reduce cardiac biochemical and histopathological alterations in high-fat diet/streptozotocin-induced diabetic rats?
RCT (n=30)
Randomized into five groups
Does red dragon fruit peel extract reduce cardiac biochemical and histopathological alterations in high-fat diet/streptozotocin-induced diabetic rats?
In a rat model of HFD/STZ-induced diabetes, red dragon fruit peel extract improved glycemic control and reduced myocardial histopathological injury, inflammation, and hypertrophy, though direct cardiac effects could not be separated from glucose-lowering effects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for red dragon fruit peel extract in diabetic cardiomyopathy; should not yet inform clinical practice.
Diabetes mellitus is associated with myocardial biochemical and structural alterations involving oxidative stress and inflammation. This study evaluated red dragon fruit peel extract (DFE) on cardiac biochemical markers and myocardial histopathology in a high-fat diet/streptozotocin (HFD/STZ) rat model of diabetes. Thirty male Wistar rats were randomised into five groups ( n = 6): non-diabetic control, diabetic control and three DFE groups (250, 500 and 1,000 mg/kg BW) administered orally once daily. The experimental period spanned 56 days from STZ induction to termination, with 51 days of treatment. Serum IL-1β, NT-proBNP and ROS, myocardial TGF-β1 immunoreactivity, and histopathological injury, inflammation and cardiomyocyte hypertrophy were assessed. DFE significantly reduced fasting blood glucose relative to the diabetic control at all three doses ( p < 0.001), with no significant differences among doses. Serum IL-1β and NT-proBNP immunoassay values were also significantly lower at all three doses ( p < 0.001), and the signal from a commercial ROS immunoassay was lower at all doses ( p < 0.05); the calibration of these three assays could not be verified and the molecular target of the ROS assay is not disclosed by its manufacturer, so their values are reported as relative between-group comparisons rather than as quantified concentrations. Histopathological injury was significantly reduced by all DFE doses, and inflammation and cardiomyocyte hypertrophy by the two higher doses (500 and 1,000 mg/kg), after correction for multiple comparisons. Myocardial TGF-β1 immunoreactivity was significantly lower at 1,000 mg/kg than in the diabetic control (corrected p = 0.022), although TGF-β1 did not differ significantly between the diabetic and non-diabetic controls (corrected p = 0.108). DFE was associated with improved glycaemic control and with reduced myocardial histopathological alteration in this model; because DFE also lowered blood glucose, its cardiac effects cannot be separated from improved glycaemic control.
No takes yet. Share an insight, caveat, or question.
Delfian et al. (2026) conducted an RCT in High-fat diet/streptozotocin-induced diabetes mellitus (n=30). Red dragon fruit (Hylocereus polyrhizus) peel extract (DFE) vs. Diabetic control and non-diabetic control was evaluated on Fasting blood glucose, serum IL-1β, NT-proBNP, ROS, myocardial TGF-β1 immunoreactivity, and myocardial histopathological injury, inflammation, and cardiomyocyte hypertrophy (p=<0.001). Red dragon fruit peel extract reduced fasting blood glucose, serum IL-1β, NT-proBNP, and myocardial histopathological injury in diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: